top of page

Advancing Tumor Organoid Drug Screening

Writer's picture: Christophe DebenChristophe Deben

In our recent webinar, we delved into the transformative potential of live-cell imaging for advancing organoid drug screening. A key focus was the critical need for standardization in the field to enhance reproducibility and efficiency across studies.


We showcased two pioneering solutions aimed at revolutionizing organoid methodologies. First, the Orbits Oncology platform, which automates image and data analysis, thereby streamlining the drug screening process and reducing error. Second, the introduction of ThermoFisher's OncoPro medium, a novel culture medium designed for easier and more effective culturing of tumoroids.


These innovations promise to accelerate the pace of research and offer more consistent and reliable data for drug screening applications. As the field grows, these tools will be instrumental in shaping the future of personalized medicine and treatment discovery.


And of course we implement both innovations at DrugVision.AI!



69 views0 comments

Comments


bottom of page